AUSTIN, Texas, Jan. 27, 2017 -- EZCORP, Inc. (Nasdaq:EZPW) will issue first quarter FY2017 results (period ending December 31, 2016) on Thursday, February 2, 2017 after the market close. We will host a conference call on Friday, February 3, 2017 at 7:30 a.m. Central Time to discuss our first quarter results. The presentation slides will be posted to the Investor Relations section of our website after the market close on Thursday, February 2, 2017.
Analysts and institutional investors may participate on the conference call by dialing (877) 201-0168, Conference ID: 62600120, International dialing (647) 788-4901. The conference call will be webcast simultaneously to the public through this link: http://investors.ezcorp.com/. A replay of the conference call will be available online at http://investors.ezcorp.com/ shortly after the call.
About EZCORP
EZCORP is a leading provider of pawn loans in the United States and Mexico. At our pawn stores, we also sell merchandise, primarily collateral forfeited from pawn lending operations and used merchandise purchased from customers.
Contact Jeff Christensen Vice President, Investor Relations Email: [email protected] Phone: (512) 437-3545


Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



